www.fdanews.com/articles/157097-cognoptix-test-identifies-alzheimer-s-disease-via-beta-amyloid-signature-in-the-eyes
Cognoptix Test Identifies Alzheimer’s Disease via Beta Amyloid Signature in the Eyes
July 16, 2013
Meanwhile, Cognoptix has suggested that its SapphireII test can find Alzheimer’s through a beta amyloid signature in the eyes.
Businesswire
Businesswire